Allison Luo - Sep 8, 2021 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
Chief Medical Officer
Signature
/a/ Timothy K. Andrews, attorney-in-fact for Allison Luo
Stock symbol
RXDX
Transactions as of
Sep 8, 2021
Transactions value $
$0
Form type
4
Date filed
9/15/2021, 08:09 PM
Next filing
Nov 16, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXDX Stock Option (Right to Buy) Award $0 +4.5K $0.00 4.5K Sep 8, 2021 Common Stock 4.5K $25.45 By Spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in 12 equal monthly installments, commencing on September 1, 2021, subject to the Reporting Person's continued service with the Issuer through each vest date.